Stay updated on ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page.

Latest updates to the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page
- Check5 days agoChange DetectedTaoyuan, Taiwan was added as a participating location and Taoyuan District, Taiwan was removed, updating the study's site list in Taiwan.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now reflects that results have been submitted (replacing the prior “No Results Posted” state). It also updates the display/version label from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check48 days agoChange DetectedThe location entry for the Italian site was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded hepatocellular carcinoma to the study conditions and updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision history updated: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page.